|Measure Name||Diagnostics||Patient Education||Treatment||Self-Management||Monitoring of Disease Status|
|1. LVEF assessment (outpatient setting)||✓||✓|
|3. Symptom and activity assessment||✓|
|4. Symptom management⁎||✓||✓|
|5. Patient self-care education⁎||✓||✓|
|6. Beta-blocker therapy for LVSD (outpatient and inpatient setting)||✓|
|7. ACE inhibitor or ARB therapy for LVSD (outpatient and inpatient setting)||✓|
|8. Counseling about ICD implantation for patients with LVSD receiving combination medical therapy⁎||✓|
ACCF indicates American College of Cardiology Foundation; ACE, angiotensin-converting enzyme; AHA, American Heart Association; AMA-PCPI, American Medical Association—Physician Consortium for Performance Improvement; ARB, angiotensin II receptor blocker; HF, heart failure; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; and LVSD, left ventricular systolic dysfunction.
↵⁎ Test measures designated for use in internal quality improvement programs only. These measures are not appropriate for any other use, for example, pay for performance, physician ranking, or public reporting programs.